580 Recruiting Trials

Clinical Trials
for Cancer in New Jersey

580 clinical trials for Cancer are currently recruiting participants at study sites in New Jersey. Study-related care is provided at no cost.

580
Recruiting trials
398
Study sites
76
Cities
259
Industry-sponsored
221
Phase 2
158
Phase 3

Cancer clinical trials in New Jersey: what to expect

Cancer is the single largest area of clinical research, and nearly every recruiting cancer trial is written for one cancer type at one stage. Most test a new drug or combination against the current standard treatment: targeted medicines matched to a mutation found in the tumor, immunotherapies that help the immune system recognize cancer cells, antibody-drug conjugates and cell therapies. Others study surgery and radiation techniques, ways to reduce side effects, and screening or prevention in people at higher risk.

In New Jersey, recruiting cancer studies are concentrated in Basking Ridge, Middletown, Montvale and New Brunswick, with sites in 72 other cities. 259 of the 580 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.

Who cancer trials usually look for

Every listing names the cancer type and stage it enrolls, and most also state how many earlier treatments you may have had: some are for people newly diagnosed, many are for cancer that has come back or spread after a first treatment stopped working. Targeted-therapy trials require a specific result on tumor testing, which the site can arrange if it has not been done. Trials generally ask that you are well enough for daily activity (a "performance status" the doctor scores), that blood counts and liver and kidney function are adequate, and that a few weeks have passed since your last treatment.

Having advanced or metastatic cancer does not rule you out. A large share of recruiting trials are designed specifically for it.

What taking part involves

Screening reviews your pathology and scans, often with new blood work and sometimes a fresh biopsy. Treatment then follows a cycle, typically every two or three weeks, with scans every six to twelve weeks to measure the response. Early-phase trials have more frequent visits at the start. The study drug and study-specific tests are provided at no cost; standard care that you would receive anyway is usually billed to insurance as normal. A placebo on its own is rare in cancer trials: when there is one, it is added to the standard treatment, and the consent form says so.

Questions worth asking the study team

Whether the trial is randomized and what the comparison treatment is; what happens if the cancer grows during the study; whether you can keep receiving the drug afterward if it is working; how the trial fits with the plan your own oncologist has suggested; and what travel or lodging support is offered. Your oncologist can also refer you directly.

Showing 20 of 580 recruiting Cancer trials in New Jersey

Acupuncture for People Experiencing Period Loss Due to Chemotherapy
PHASE2 Basking Ridge, New Jersey +4 sites NCT06915116
This trial is looking for women aged 15 to 40 who have lost their periods after chemotherapy for cancer. Participants will receive acupuncture and share how it affects their menstrual cycles and symptoms.
Recruiting
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
PHASE1 Santa Monica, California +4 sites NCT07540572
This trial is looking for adults with advanced solid tumors such as breast cancer, lung cancer, prostate cancer, or colorectal cancer. Participants will receive IDE574, either alone or with another treatment, and will be monitored for safety and effectiveness.
Recruiting
Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors
NA Basking Ridge, New Jersey +4 sites NCT07454330
This trial is looking for Chinese cancer patients and survivors who want help improving their quality of life. Participants will attend education sessions, counseling, and support meetings, which can be done via phone or video.
Recruiting
A Study of Music Therapy for Anxiety in People With Cancer
NA Basking Ridge, New Jersey +4 sites NCT07845422
This trial is looking for adults with advanced cancer who experience anxiety. Participants will try two different music-based therapies to see which helps reduce their anxiety and improve their sense of connection and coping skills.
Recruiting
A Youth-led Intervention to Reduce Healthcare Disparities in Cancer Screening
NA New Brunswick, New Jersey NCT07008781
This trial is looking for students aged 15-18 and their adult family members to help increase awareness of cancer screening in their community. Participants will engage in activities aimed at encouraging adults who need screenings to take action.
Recruiting
Prospective Study to Assess a Diagnostic Aid for Cancer
N/A Coronado, California +4 sites NCT07046260
This trial is looking for people aged 45 and older who have symptoms that might suggest cancer. Participants will take a blood test and may also have additional standard tests to see if cancer is present.
Recruiting
Discovering New Genetic Markers in Adults and Children Who May Be At Risk for Hereditary Forms of Cancer
N/A Basking Ridge, New Jersey +4 sites NCT03922893
This trial is looking for adults and children who may have a genetic risk for cancer. Participants will be involved in research to help identify genetic changes that could lead to earlier cancer detection or reduced cancer risk.
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
PHASE3 Birmingham, Alabama +4 sites NCT06058377
This trial is looking for women with hormone receptor positive, HER2 negative stage II-III breast cancer. Participants will receive standard chemotherapy along with an immunotherapy drug called durvalumab to see if it helps prevent cancer from coming back.
Recruiting
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
PHASE3 Bakersfield, California +4 sites NCT06345729
This trial is looking for adults diagnosed with a specific type of lung cancer called non-small cell lung cancer (NSCLC) that has a certain genetic mutation. Participants will receive a combination of two drugs, calderasib and pembrolizumab, to see how well they work together as a first treatment option.
Recruiting
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
PHASE3 Mobile, Alabama +4 sites NCT06510374
This trial is looking for people with intermediate risk non-muscle invasive bladder cancer. Participants will either receive a treatment called Nadofaragene Firadenovec or be monitored without treatment.
Recruiting
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
PHASE3 Tucson, Arizona +4 sites NCT06545955
This trial is looking for adults with a specific type of bladder cancer called carcinoma in situ (CIS) who have not responded to previous treatments. Participants will receive a treatment called nadofaragene firadenovec, either alone or with other therapies, to see how well it works.
Recruiting
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
PHASE3 Birmingham, Alabama +4 sites NCT07190248
This trial is looking for people with a type of lung cancer called non-small cell lung cancer. Participants will receive a combination of two treatments to see if they can help them live longer without the cancer getting worse.
Recruiting
A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)
PHASE3 Huntsville, Alabama +4 sites NCT07541079
This trial is looking for women with early breast cancer who have had problems with a previous hormonal treatment. If you join, you will switch to taking giredestrant as part of your cancer care.
Recruiting
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
PHASE3 New Brunswick, New Jersey +4 sites NCT07554339
This trial is looking for people with locally advanced non-small cell lung cancer who have a specific gene mutation. Participants will receive a treatment combination of calderasib and durvalumab after chemotherapy and radiation, and researchers want to see if this helps them live longer without the cancer getting worse.
Recruiting
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
PHASE3 Springdale, Arkansas +4 sites NCT07625644
This trial is looking for adults with extensive-stage small cell lung cancer who have not received treatment before. Participants will receive a combination of two medications, BL-M14D1 and Atezolizumab, to see how well it works compared to standard therapy.
Recruiting
Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease
PHASE3 Fort Lauderdale, Florida +4 sites NCT07750158
This trial is looking for people with colorectal cancer who have completed their initial treatment and show signs of disease. Participants will receive either zanzalintinib alone or in combination with other drugs compared to a placebo.
Recruiting
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
PHASE3 Little Rock, Arkansas +4 sites NCT06312137
This trial is looking for adults with a type of lung cancer called non-small cell lung cancer who did not have a complete response after surgery. Participants will receive medications to see if adding sacituzumab to pembrolizumab helps them stay cancer-free longer.
Recruiting
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
PHASE3 Birmingham, Alabama +4 sites NCT06824467
This trial is looking for women with certain types of ovarian cancer who have had previous chemotherapy. Participants will receive a treatment to see if it helps them live longer without their cancer worsening.
Recruiting
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
PHASE3 Mobile, Alabama +4 sites NCT06952504
This trial is looking for people with advanced or recurring endometrial cancer that has specific characteristics. Participants will receive a combination of two medicines, sacituzumab tirumotecan and pembrolizumab, to see if it helps them live longer or keeps the cancer from worsening.
Recruiting
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
PHASE3 Newport Beach, California +4 sites NCT07419295
This trial is looking for people with bladder cancer that has spread or got worse after previous treatments. Participants will receive a new treatment called sacituzumab tirumotecan and be compared to those receiving standard chemotherapy options.
Recruiting

Where the Cancer studies are in New Jersey

  • Rutgers Cancer Institute of New Jersey, New Brunswick77 trials
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale57 trials
  • Memorial Sloan Kettering Monmouth, Middletown54 trials
  • Memorial Sloan Kettering Bergen, Montvale53 trials
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge52 trials
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown51 trials

Counts are recruiting studies listing at least one site in New Jersey, from ClinicalTrials.gov, refreshed every two days.

Cancer clinical trials in New Jersey: common questions

How many Cancer clinical trials are recruiting in New Jersey?
TrialFinder currently lists 580 recruiting Cancer clinical trials with study sites in New Jersey. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Cancer clinical trials located in New Jersey?
Study sites for the Cancer trials listed on this page include Basking Ridge, New Brunswick. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Cancer clinical trial in New Jersey?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Cancer trials in New Jersey also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Cancer clinical trial in New Jersey?
Each study sets its own criteria based on age, Cancer diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.
Will I get a placebo instead of cancer treatment?
Almost never. Cancer trials compare a new treatment with the current standard treatment, or add the study drug to standard treatment. When a placebo is used it is on top of standard care, and the consent form states this before you decide.
Can I join a cancer trial if my cancer has spread?
Yes. Many recruiting cancer trials are written for advanced or metastatic disease, including people whose earlier treatments have stopped working. The listing states the stage and prior treatments it accepts.
Do I have to stop my current cancer treatment to join a trial?
It depends on the trial. Some enroll people whose current treatment has stopped working, some add the study drug to the treatment you are on, and some are for people who have not started treatment yet. Ask the study team before changing anything.
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to Cancer trials near you in New Jersey.

Get Matched — Free
No insurance required

Breast cancer trials test new chemotherapy regimens, immunotherapy combinations, targeted therapies, and early-detection methods across all stages of breast cancer.

All Cancer trials →